Clinical trials
Treatment clinical trials
Below are recruiting treatment clinical trials, each written for real people, not researchers. We’re tracking 8,322 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07519902RecruitingPhase 3
Cenegermin Eye Drops for Persistent Corneal Ulcers
This study tests whether cenegermin eye drops help heal stubborn corneal ulcers (open sores on the clear front of the eye) that haven't improved with standard treatments like lubricating drops or contact lenses.
Huntington Beach, CaliforniaAges 18 years+ - NCT07523750Recruiting
Pulsed field ablation for persistent atrial fibrillation
This study tests two types of pulsed field ablation catheters to treat persistent atrial fibrillation, a heart rhythm problem lasting more than 7 days but less than a year. The goal is to see if these catheters can safely and effectively restore a normal heart rhythm.
Jonesboro, ArkansasAges 18–80 - NCT07520747Recruiting
Korean Children's IBD Disease and Treatment Database Study
This study looks at health records of children in Korea who have inflammatory bowel disease (Crohn's disease or ulcerative colitis) to understand their medical care, treatments, and healthcare use. Researchers are not testing a new drug—they're analyzing existing medical information to learn more about how these diseases are managed in children.
SuwonAges Up to 17 years - NCT07520565RecruitingPhase 3
Emergency stroke treatment with BXOS110 within 3 hours
This trial tests whether BXOS110, an experimental injection, can help people recover better after an acute ischemic stroke (a stroke caused by a blood clot) when given within 3 hours of symptom onset. The study compares BXOS110 to a placebo to see if it reduces disability and improves recovery.
Hengshui, HebeiAges 18–85 - NCT07517757Recruiting
Diet strategies for fibromyalgia in overweight women
This study tests whether specific eating plans can help reduce fibromyalgia symptoms (widespread pain and fatigue) in women who are overweight or obese. Fibromyalgia causes chronic body pain and tiredness, and this trial explores whether changing diet may improve how you feel.
Genova, GenovaAges 18–65 - NCT07522762Recruiting
Long-term life after advanced GIST on targeted drug therapy
This study follows people who have been taking targeted cancer drugs (called TKIs) for advanced GIST for at least 2 years to understand how these long-term treatments affect quality of life, side effects, and daily living. Researchers want to learn what challenges patients face and how to better support them.
Amsterdam, North HollandAges 18 years+ - NCT07522385Enrolling by invitation
Endoscopic ultrasound treatment for gallstones while keeping gallbladder
This study tests a minimally invasive procedure that uses ultrasound guidance to create a small opening between your gallbladder and stomach or small intestine, allowing gallstones to pass without removing your gallbladder. It may help if you have symptoms from gallstones but want to preserve your gallbladder.
Wuhan, HubeiAges 18–80 - NCT07523386Recruiting
Cannulated Screws vs. K-wires for Wrist Fracture Surgery
This study compares two surgical methods for fixing broken wrist bones in adults. Researchers want to see which approach—using special screws or wires—works better for healing and function.
Sohag, Naser CityAges 18–60 - NCT07516249Recruiting
Cartoons and Stories to Help Kids Feel Better During Breathing Treatments
This study tests whether watching cartoons and hearing interactive stories can help children aged 6–9 feel less scared and more comfortable while using a nebulizer (a machine that turns medicine into a mist to breathe in). The goal is to see if distraction and engaging storytelling make the treatment easier for kids.
MersinAges 6–9 - NCT07523022Enrolling by invitationPhase 4
Fertility Treatments for Low Sperm Count or Quality
This study compares two different hormone treatments to see which one better improves sperm health and increases pregnancy chances in men with low or abnormal sperm. You'll receive either injections or pills designed to boost sperm production.
SzegedAges 18 years+ - NCT07518979RecruitingPhase 2
EGFR-targeted drug plus immunotherapy for advanced penile cancer
This trial tests a new combination treatment for advanced penile cancer that hasn't been treated before. It combines a targeted drug (becotatug vedotin) designed to attack cancer cells with an immunotherapy drug (pucotenlimab) that helps your immune system fight cancer.
Chengdu, SichuanAges 18 years+ - NCT07524452RecruitingPhase 3
Becotatug vedotin plus immunotherapy for head and neck cancer
This trial tests a new combination of two drugs—becotatug vedotin (a targeted therapy) and a PD-1 inhibitor (an immunotherapy)—given before surgery to treat advanced head and neck squamous cell carcinoma. The goal is to shrink tumors and improve surgical outcomes for patients with specific cancer markers.
Zhuhai, GuangdongAges 18–75 - NCT07517185RecruitingPhase 2
Early aggressive treatment for relapsing multiple sclerosis
This trial tests whether treating relapsing multiple sclerosis (RRMS) aggressively and early with a specific medication can slow disease progression. You may qualify if you were recently diagnosed, have had recent disease activity, and are willing to take a strong immunosuppressive drug with regular MRI monitoring.
FalunAges 18–50 - NCT07524218Recruiting
Meal Timing During Cancer Treatment Recovery
This study looks at how the timing of meals during cancer treatment recovery affects how well you tolerate and respond to your therapy. Researchers want to learn whether eating during certain hours of the day might help your body handle chemotherapy, targeted drugs, or immunotherapy better.
Los Angeles, CaliforniaAges 18 years+ - NCT07521943Recruiting
Hand Bone Fracture Treatment Study
This study tests the best way to treat certain broken bones in your hand (specifically in the middle section of bones that support your fingers). Researchers want to see if a newer treatment approach helps your hand heal better and work normally again.
Stockholm, Stockholm CountyAges 18 years+ - NCT07517536Enrolling by invitation
CHT105 treatment for hard-to-treat lupus kidney disease
This study tests a new medicine called CHT105 for lupus patients whose kidney disease hasn't improved with standard treatments. The medicine targets specific immune cells that may be driving the kidney damage.
Nanjing, JiangsuAges 18–65 - NCT07517510Enrolling by invitationPhase 2
HVA treatment for newly diagnosed mixed-phenotype acute leukemia
This study tests a drug called HVA to treat mixed-phenotype acute leukemia (MPAL), a rare blood cancer that has features of both lymphoblastic and myeloid leukemias. You may qualify if you've just been diagnosed and haven't started strong anti-cancer treatment yet.
Guangzhou, GuangdongAges 18 years+ - NCT07519187RecruitingEarly Phase 1
CAR-T Cell Therapy for Hard-to-Treat Blood Cancers
This trial tests a new type of cell therapy called CAR-T cells that are designed to recognize and attack cancer cells in patients with multiple myeloma, plasmacytoma, plasma cell leukemia, or light chain amyloidosis that have not responded well to previous treatments. The goal is to see if this approach can help patients whose cancers have become resistant to standard medicines.
Chengdu, ChengduAges 18–75 - NCT07524426Recruiting
Local Radiation Therapy for Bladder Cancer Not Suitable for Surgery
This trial tests whether focused radiation therapy directed at the bladder can help patients with muscle-invasive bladder cancer who are not candidates for surgical removal or have chosen not to have surgery. The goal is to see if this approach can control the cancer and improve quality of life.
Umeå, Västerbotten CountyAges 18 years+ - NCT06757023Recruiting
Acupuncture for better sleep after breast cancer surgery
This study tests if thumbtack needle therapy (a type of acupuncture) can improve sleep and recovery in women after breast cancer surgery. If you're between 18 and 55 and having breast cancer surgery with general anesthesia, you may be eligible.
Xiamen, FujianAges 18–55 - NCT06754475Recruiting
Low volume arm HIIT for heart failure patients
This trial tests if short, high-intensity arm exercises can help people with stable heart failure. It looks at safety and improvements in daily function.
Mersin, MersinAges 18 years+ - NCT06757153RecruitingEarly Phase 1
NRG-103 injection for recurrent glioblastoma patients
This trial tests an injection called NRG-103 given directly into the cavity where a recurrent brain tumor was removed. It is for people with glioblastoma that has come back and who have already had standard treatments.
Wuhan, HubeiAges 18 years+ - NCT06758050Recruiting
Core exercises for front knee pain
This study tests whether doing core exercises can help reduce knee pain in people with patellofemoral pain syndrome—pain at the front of the knee that comes on gradually. It is meant for young adults with a healthy weight who have had this type of knee pain for more than 3 months.
GizaAges 18–35 - NCT06301412RecruitingPhase 3
Cooling plus clot removal for acute stroke
This trial tests whether cooling the body down (hypothermia) combined with a clot removal procedure (thrombectomy) helps people recover better from a large-artery stroke. You may be eligible if you have a moderate-to-severe stroke and can be treated within 24 hours of when you were last seen well.
Freiburg im BreisgauAges 18 years+
Hear when a new Treatment trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for treatment?
- Yes. Clin2 currently lists 8,322 recruiting treatment studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a treatment trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a treatment trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.